|
JP2007530417A
(ja)
|
2003-07-01 |
2007-11-01 |
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ |
細胞及び生物の寿命及びストレス応答を操作するための組成物
|
|
US20050158376A1
(en)
*
|
2003-10-23 |
2005-07-21 |
Sardi William F. |
Dietary supplement and method of processing same
|
|
US20090169585A1
(en)
*
|
2003-10-23 |
2009-07-02 |
Resveratrol Partners, Llc |
Resveratrol-Containing Compositions And Their Use In Modulating Gene Product Concentration Or Activity
|
|
US8017634B2
(en)
|
2003-12-29 |
2011-09-13 |
President And Fellows Of Harvard College |
Compositions for treating obesity and insulin resistance disorders
|
|
US20050171027A1
(en)
|
2003-12-29 |
2005-08-04 |
President And Fellows Of Harvard College |
Compositions for treating or preventing obesity and insulin resistance disorders
|
|
WO2005069998A2
(en)
*
|
2004-01-20 |
2005-08-04 |
Brigham Young University Technology Transfer Office |
Novel sirtuin activating compounds and methods for making the same
|
|
CN1964627B
(zh)
*
|
2004-06-04 |
2011-10-19 |
华盛顿大学 |
治疗神经病变的方法和组合物
|
|
NZ552397A
(en)
|
2004-07-15 |
2011-04-29 |
Amr Technology Inc |
Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
|
|
EP1850840A2
(en)
*
|
2005-01-13 |
2007-11-07 |
Sirtris Pharmaceuticals, Inc. |
Novel compositions for preventing and treating neurodegenerative and blood coagulation disorders
|
|
US20090142335A1
(en)
*
|
2005-02-15 |
2009-06-04 |
Joslin Diabetes Center |
Methods of diagnosis and treatment of metabolic disorders
|
|
WO2006104586A2
(en)
*
|
2005-02-15 |
2006-10-05 |
Joslin Diabetes Center |
Methods of diagnosis and treatment of metabolic disorders
|
|
US20070014833A1
(en)
*
|
2005-03-30 |
2007-01-18 |
Sirtris Pharmaceuticals, Inc. |
Treatment of eye disorders with sirtuin modulators
|
|
EP2805719A1
(en)
*
|
2005-03-30 |
2014-11-26 |
Glaxosmithkline LLC |
Nicotinamide riboside and analogues thereof
|
|
ES2600460T3
(es)
|
2005-05-10 |
2017-02-09 |
Intermune, Inc. |
Derivados de piridona-2-ona como moduladores del sistema de proteína cinasa activada por estrés
|
|
US8546423B2
(en)
|
2005-05-18 |
2013-10-01 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
|
US20060292099A1
(en)
*
|
2005-05-25 |
2006-12-28 |
Michael Milburn |
Treatment of eye disorders with sirtuin modulators
|
|
WO2006138418A2
(en)
|
2005-06-14 |
2006-12-28 |
President And Fellows Of Harvard College |
Improvement of cognitive performance with sirtuin activators
|
|
US20070149466A1
(en)
*
|
2005-07-07 |
2007-06-28 |
Michael Milburn |
Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
|
|
CN101176786A
(zh)
*
|
2006-11-08 |
2008-05-14 |
中国科学院上海生命科学研究院 |
增加胰岛素敏感性的方法和组合物
|
|
WO2008060400A2
(en)
*
|
2006-11-15 |
2008-05-22 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin polymorphisms and methods of use thereof
|
|
ES2660173T3
(es)
*
|
2007-01-16 |
2018-03-21 |
Ipintl, Llc |
Nueva composición para el tratamiento del síndrome metabólico
|
|
WO2008119070A1
(en)
*
|
2007-03-28 |
2008-10-02 |
Trustees Of Boston University |
Methods of treatment using sirt modulators and compositions containing sirt1 modulators
|
|
US8404275B2
(en)
*
|
2007-07-01 |
2013-03-26 |
Vitalis Llc |
Combination tablet with chewable outer layer
|
|
EP2170051A1
(en)
*
|
2007-07-01 |
2010-04-07 |
Joseph Peter Habboushe |
Combination tablet with chewable outer layer
|
|
EP2018861A1
(en)
*
|
2007-07-26 |
2009-01-28 |
Laboratorios del Dr. Esteve S.A. |
5HT6-Ligands such as sulfonamide derivatives in drug-induced weight-gain
|
|
JP5337405B2
(ja)
|
2007-09-17 |
2013-11-06 |
ザ・ホスピタル・フォー・シック・チルドレン |
ゴーシェ病の治療方法
|
|
US9339500B2
(en)
*
|
2008-03-04 |
2016-05-17 |
Intra-Cellular Therapies, Inc. |
Methods of treating vasomotor symptoms
|
|
CA2724023C
(en)
*
|
2008-05-13 |
2014-02-18 |
Genmedica Therapeutics Sl |
Salicylate conjugates useful for treating metabolic disorders
|
|
CA2666036C
(en)
*
|
2008-05-16 |
2017-09-12 |
Chien-Hung Chen |
Novel compositions and methods for treating hyperproliferative diseases
|
|
CN102099036B
(zh)
|
2008-06-03 |
2015-05-27 |
英特芒尼公司 |
用于治疗炎性疾患和纤维化疾患的化合物和方法
|
|
US9156812B2
(en)
|
2008-06-04 |
2015-10-13 |
Bristol-Myers Squibb Company |
Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
|
|
WO2010011836A2
(en)
*
|
2008-07-25 |
2010-01-28 |
Emory University |
Treating various disorders with 7,8-dihydroxyflavone and derivatives thereof
|
|
CA2739893C
(en)
|
2008-10-07 |
2016-10-04 |
Mpex Pharmaceuticals, Inc. |
Inhalation of levofloxacin for reducing lung inflammation
|
|
KR101959873B1
(ko)
|
2008-10-07 |
2019-03-19 |
랩터 파마슈티컬스 인코포레이티드 |
약동학 개선을 위한 에어로졸 플루오로퀴놀론 제형
|
|
US20100239552A1
(en)
*
|
2009-03-16 |
2010-09-23 |
Genmedica Therapeutics Sl |
Combination Therapies for Treating Metabolic Disorders
|
|
WO2010107702A1
(en)
*
|
2009-03-16 |
2010-09-23 |
Ipintl, Llc |
Treating alzheimer's disease and osteoporosis and reducing aging
|
|
JP2012520342A
(ja)
*
|
2009-03-16 |
2012-09-06 |
ジェンメディカ・セラピューティックス・ソシエダッド・リミターダ |
代謝障害を処置するのに有用な抗炎症剤および抗酸化剤のコンジュゲート
|
|
AU2010247735B2
(en)
|
2009-05-12 |
2015-07-16 |
Albany Molecular Research, Inc. |
Crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)- 1,2,3,4-tetrahydroisoquinoline and use thereof
|
|
WO2010132437A1
(en)
|
2009-05-12 |
2010-11-18 |
Albany Molecular Research, Inc. |
Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
|
|
AU2010247763B2
(en)
*
|
2009-05-12 |
2015-12-24 |
Albany Molecular Research, Inc. |
7-([1,2,4,]triazolo[1,5,-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4- tetrahydroisoquinoline and use thereof
|
|
WO2011002673A1
(en)
*
|
2009-07-01 |
2011-01-06 |
Temple University - Of The Commonwealth System Of Higher Education |
Leptin agonist and methods of use
|
|
AU2010289397B2
(en)
|
2009-09-03 |
2016-05-26 |
Bioenergenix |
Heterocyclic compounds for the inhibition of PASK
|
|
WO2011029059A1
(en)
|
2009-09-04 |
2011-03-10 |
Mpex Pharmaceuticals, Inc. |
Use of aerosolized levofloxacin for treating cystic fibrosis
|
|
FI20106119A0
(fi)
*
|
2010-10-27 |
2010-10-27 |
Sirtuin Valley Oy |
Energia-aineenvaihduntaan vaikuttava koostumus
|
|
US8466197B2
(en)
|
2010-12-14 |
2013-06-18 |
Genmedica Therapeutics Sl |
Thiocarbonates as anti-inflammatory and antioxidant compounds useful for treating metabolic disorders
|
|
WO2012094462A2
(en)
|
2011-01-05 |
2012-07-12 |
Bioenergenix |
Heterocyclic compounds for the inhibition of pask
|
|
US8916561B2
(en)
|
2011-03-02 |
2014-12-23 |
Bioenergenix, Llc |
Substituted quinoxaline compounds for the inhibition of PASK
|
|
WO2012119046A2
(en)
|
2011-03-02 |
2012-09-07 |
Bioenergenix |
Heterocyclic compounds for the inhibition of pask
|
|
EP2898923A3
(en)
*
|
2011-04-15 |
2015-10-07 |
Nestec S.A. |
Isoflavones for regulating sirtuin gene expression
|
|
JP2012236793A
(ja)
*
|
2011-05-11 |
2012-12-06 |
Kikkoman Corp |
Ａｍｐｋ活性化剤
|
|
RU2631597C2
(ru)
|
2011-07-15 |
2017-09-25 |
Нусерт Сайенсиз, Инк. |
Композиции и способы модулирования метаболических путей
|
|
CA2853804C
(en)
|
2011-10-28 |
2021-06-01 |
Vitalis Llc |
Anti-flush compositions
|
|
US8916528B2
(en)
|
2011-11-16 |
2014-12-23 |
Resveratrol Partners, Llc |
Compositions containing resveratrol and nucleotides
|
|
US9745279B2
(en)
|
2011-12-27 |
2017-08-29 |
Tokiwa Phytochemical Co., Ltd. |
Sirtuin activator
|
|
JO3407B1
(ar)
|
2012-05-31 |
2019-10-20 |
Eisai R&D Man Co Ltd |
مركبات رباعي هيدرو بيرازولو بيريميدين
|
|
AR092742A1
(es)
|
2012-10-02 |
2015-04-29 |
Intermune Inc |
Piridinonas antifibroticas
|
|
TWI485145B
(zh)
|
2012-10-26 |
2015-05-21 |
財團法人工業技術研究院 |
Ｐ型有機半導體材料與光電元件
|
|
SG10201709195TA
(en)
|
2012-11-13 |
2017-12-28 |
Nusirt Sciences Inc |
Compositions and methods for increasing energy metabolism
|
|
CN105228627B
(zh)
*
|
2013-03-15 |
2018-07-13 |
纽斯尔特科学公司 |
亮氨酸和烟酸降低脂质水平
|
|
EP2801357A1
(en)
|
2013-05-10 |
2014-11-12 |
IMD Natural Solutions GmbH |
Carboxylated stilbenes for activating AMPK and sirtuins
|
|
MX382781B
(es)
|
2014-04-02 |
2025-03-13 |
Intermune Inc |
Piridinonas anti-fibroticas.
|
|
BR112017017619A2
(pt)
|
2015-02-19 |
2018-05-08 |
Purdue Pharma Lp |
métodos e composições para diminuir esvaziamento gástrico
|
|
CN105153090A
(zh)
*
|
2015-07-17 |
2015-12-16 |
浙江海洋学院 |
4′-溴-7-异戊烯氧基-2,3-二氢黄酮和制备方法以及在制备抗抑郁药物中的应用
|
|
CN105380955A
(zh)
*
|
2015-09-24 |
2016-03-09 |
成都普瑞法科技开发有限公司 |
土大黄苷在治疗溃疡性结肠炎药物中的应用
|
|
US20180169085A1
(en)
*
|
2016-12-19 |
2018-06-21 |
Augusta University Reserch Institute, Inc. |
Combination Therapy for Hemorrhagic Injury
|
|
WO2019108877A1
(en)
*
|
2017-12-01 |
2019-06-06 |
University Of Hawaii |
GSK-3β INHIBITORS AND USE THEREOF IN METHODS OF TREATMENT
|
|
US20210393621A1
(en)
|
2018-10-26 |
2021-12-23 |
The Research Foundation For The State University Of New York |
Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia
|
|
IT201900003325A1
(it)
*
|
2019-03-07 |
2020-09-07 |
C I A M S R L |
Composizione per la prevenzione e trattamento della dermatite atopica
|
|
WO2021096882A1
(en)
*
|
2019-11-11 |
2021-05-20 |
Nusirt Sciences, Inc. |
Compositions, methods and kits for altering adipocytes
|
|
CA3235146A1
(en)
|
2021-10-14 |
2023-04-20 |
Incyte Corporation |
Quinoline compounds as inhibitors of kras
|
|
WO2025049514A1
(en)
*
|
2023-08-30 |
2025-03-06 |
Sirona Biosciences Inc. |
Compositions and methods with flavonoids
|